LYOPHILIZATION SPOTLIGHT: Norman Chieng
Name: Norman Chieng, PhD
Alcami Site: Charleston, SC
What is your role? I am a senior scientist in...
Alcami is a US-based contract development, testing, and manufacturing organization for pharma and biotech companies. Since 1979, we support our clients in making their projects go from potential to reality day-after-day. Core Capabilities: - Sterile fill-finish development and manufacturing - Oral solid dose development and manufacturing - Laboratory development & testing services Our mission is to unlock the potential of transformative medicines for our customers. Specialties: Sterile Fill-Finish Development & Manufacturing, Oral Solid Dose Development & Manufacturing, Laboratory Services, Environmental Monitoring, Packaging & Labeling, Analytical Testing, Development Testing, Cleanroom Services, Chemistry, Microbiology, Stability, Formulation Development, Analytical Development, Full-Time Equivalent (FTE) Programs, Food Studies, ICP-MS Capabilities, Extractables & Leachables, Rapid Sterility, Companion Animal Health, Abuse-Deterrence Testing, and Biologics Analytical Development
Name: Norman Chieng, PhD
Alcami Site: Charleston, SC
What is your role? I am a senior scientist in...
There are three main types of packaging – primary, secondary, and tertiary – and it is important to...
Durham, NC (USA) – October 8, 2019 – Alcami Corporation, a leading provider of fully-integrated...
Supporting a compound from discovery to clinical phases and potentially commercial phases requires...
Stability testing is a fundamental part of the drug development process— upholding the quality of...
According to Dr. John Metcalfe, “pharmaceutical companies go to great lengths to manufacture a drug...
The US Orphan Drug Act of 1983 characterizes an orphan disease as a rare medical condition that...
Many pharmaceutical manufacturers are concerned about label design and placement to accommodate a...
Controlled drug substances are scheduled based on medical use in treatment, potential for abuse,...
Durham, NC (USA) – October 25, 2018 – Alcami Corporation, a leading provider of fully-integrated...
Name: Steven Froelich
Requirements from regulatory agencies have become increasingly rigorous with regards to the...
Project Call 1.0 Proposal Selected by NIIMBL Governing Committee
According to the US Orphan Drug Act of 1983, a rare disease is defined as a condition that affects...
The use of opioid medications for pain management continues to increase, generating an inevitable...
An FTE agreement is considered a comprehensive analytical service that allows pharmaceutical and...
Wilmington, NC (USA) – June 14, 2018 – Alcami Corporation, a leading provider of fully-integrated...
Durham, NC (USA) – June 13, 2018 – Alcami Corporation, a leading provider of fully-integrated...
The Food and Drug Administration (FDA) issued a draft guidance listing the enforcement of product...